Cargando…
Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review
BACKGROUND: Ketamine has emerged as a rapid-acting antidepressant in treatment-resistant depression (TRD) increasingly used in non-research, clinical settings. Few studies, however, have examined neurocognitive effects of repeated racemic ketamine infusion treatments in patients with TRD. In an effo...
Autores principales: | Dai, Danika, Miller, Courtney, Valdivia, Violeta, Boyle, Brian, Bolton, Paula, Li, Shuang, Seiner, Steve, Meisner, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862573/ https://www.ncbi.nlm.nih.gov/pubmed/35193541 http://dx.doi.org/10.1186/s12888-022-03789-3 |
Ejemplares similares
-
Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021) -
On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods
por: Strong, C.E., et al.
Publicado: (2018) -
Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study
por: Zheng, Wei, et al.
Publicado: (2020) -
Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic
por: Rosenblat, Joshua D., et al.
Publicado: (2021) -
Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)